Travere Therapeutics (TVTX) Current Taxes (2015 - 2017)

Travere Therapeutics (TVTX) reported Current Taxes of $1.2 million for Q3 2017, down 70.3% on a YoY basis from $3.9 million in Q3 2016, and down 70.3% quarter-over-quarter from $3.9 million in Q3 2016.

Travere Therapeutics (TVTX) Current Taxes (2015 - 2017) Analysis & Trends

Travere Therapeutics has reported Current Taxes for 3 years, with the latest figure at $1.2 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 10,460.56
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 19.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Travere Therapeutics 5.07 Bn 4.99 Bn 102.38 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 1.15 Mn
Sep 30, 2016 3.88 Mn
Sep 30, 2015 9.63 Mn